Could a common stroke drug help people with a rare brain disease?

NCT ID NCT07518810

First seen Apr 30, 2026 · Last updated May 16, 2026 · Updated 5 times

Summary

This study tests whether a drug called butylphthalide can improve symptoms of multiple system atrophy (MSA), a rare brain disorder. About 150 adults with MSA will take either the drug or a placebo for 6 months. Researchers will measure changes in movement and daily function to see if the drug helps control symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Beijing Chaoyang Hospital of Capital Medical University

    Beijing, China

    Contact

  • HuZhou Central Hospital

    Huzhou, Zhejiang, China

    Contact

  • Ningbo Second Hospital

    Ningbo, Zhejiang, China

    Contact

  • Taizhou Hospital of Zhejiang Province

    Taizhou, Zhejiang, China

    Contact

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

    Contact

  • The Second Hospital of Jiaxing

    Jiaxing, Zhejiang, China

    Contact

Conditions

Explore the condition pages connected to this study.